-
1
-
-
84885864792
-
-
Association for Molecular Pathology et al v. Myriad Genetics, Inc., et al., No. 12-398 (U. S. June 13, 2013). Retrieved from
-
Association for Molecular Pathology et al v. Myriad Genetics, Inc., et al., No. 12-398 (U. S. June 13, 2013). Retrieved from http://www. supremecourt. gov/.
-
-
-
-
2
-
-
84885847392
-
-
Association for Molecular Pathology et al v. United States Patent and Trademark Office et al 702 F. Supp. 2d 181 (S. D. New York 2010)
-
Association for Molecular Pathology et al v. United States Patent and Trademark Office et al 702 F. Supp. 2d 181 (S. D. New York 2010).
-
-
-
-
3
-
-
34250325499
-
Effectiveness of preventive interventions in BRCA1/2 gene mutation carriers: A systematic review
-
doi:10.1002/ijc.22817
-
Bermejo-Perez, M. L., Marquez-Calderon, S., & Llanos-Mendez, A. (2007). Effectiveness of preventive interventions in BRCA1/2 gene mutation carriers: A systematic review. International Journal of Cancer, 121(2), 225-231. doi: 10. 1002/ijc. 22817.
-
(2007)
International Journal of Cancer
, vol.121
, Issue.2
, pp. 225-231
-
-
Bermejo-Perez, M.L.1
Marquez-Calderon, S.2
Llanos-Mendez, A.3
-
4
-
-
77951486616
-
Impact of gene patents and licensing practices on access to genetic testing for cystic fibrosis
-
doi:10.1097/GIM.0b013e3181d7cf7d
-
Chandrasekharan, S., Heaney, C., James, T., Conover, C., & Cook-Deegan, R. (2010). Impact of gene patents and licensing practices on access to genetic testing for cystic fibrosis. Genetics in Medicine, 12(4), S194-S211. doi: 10. 1097/GIM. 0b013e3181d7cf7d.
-
(2010)
Genetics in Medicine
, vol.12
, Issue.4
-
-
Chandrasekharan, S.1
Heaney, C.2
James, T.3
Conover, C.4
Cook-Deegan, R.5
-
5
-
-
77957802804
-
Patently unpatentable: Implications of the Myriad court decision on genetic diagnostics
-
doi:10.1016/j.tibtech.2010.08.005
-
Cho, M. (2010). Patently unpatentable: Implications of the Myriad court decision on genetic diagnostics. Trends in Biotechnology, 28(11), 548-551. doi: 10. 1016/j. tibtech. 2010. 08. 005.
-
(2010)
Trends in Biotechnology
, vol.28
, Issue.11
, pp. 548-551
-
-
Cho, M.1
-
6
-
-
77954110546
-
Gene patents
-
In M. Crowley (Ed.), Garrison, NY: The Hastings Center. Retrieved from
-
Cook-Deegan, R. (2008). Gene patents. In M. Crowley (Ed.), From Birth to Death and Bench to Clinic: The Hastings Center Bioethics Briefing Book for Journalists, Policymakers, and Campaigns (pp. 69-72). Garrison, NY: The Hastings Center. Retrieved from http://www. thehastingscenter. org/.
-
(2008)
From Birth to Death and Bench to Clinic: The Hastings Center Bioethics Briefing Book for Journalists, Policymakers, and Campaigns
, pp. 69-72
-
-
Cook-Deegan, R.1
-
7
-
-
77951479651
-
Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: Comparing breast and ovarian cancers with colon cancers
-
doi:10.1097/GIM.0b013e3181d5a67b
-
Cook-Deegan, R., DeRienzo, C., Carbone, J., Chandrasekharan, S., Heaney, C., & Conover, C. (2010). Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: Comparing breast and ovarian cancers with colon cancers. Genetics in Medicine, 12(4), S15-S38. doi: 10. 1097/GIM. 0b013e3181d5a67b.
-
(2010)
Genetics in Medicine
, vol.12
, Issue.4
-
-
Cook-Deegan, R.1
DeRienzo, C.2
Carbone, J.3
Chandrasekharan, S.4
Heaney, C.5
Conover, C.6
-
8
-
-
77951454005
-
Myriad genetics: In the eye of the policy storm
-
doi:10.1097/GIM.0b013e3181d72661
-
Gold, E. R., & Carbone, J. (2010). Myriad genetics: In the eye of the policy storm. Genetics in Medicine, 12(4), S39-S70. doi: 10. 1097/GIM. 0b013e3181d72661.
-
(2010)
Genetics in Medicine
, vol.12
, Issue.4
-
-
Gold, E.R.1
Carbone, J.2
-
9
-
-
84885855752
-
Ethics and the patenting of human genes
-
Retrieved from
-
Lever, A. (2001). Ethics and the patenting of human genes. The Journal of Philosophy, Science & Law, 1. Retrieved from http://jpsl. org/.
-
(2001)
The Journal of Philosophy, Science & Law
, vol.1
-
-
Lever, A.1
-
10
-
-
0036986505
-
Patent or perish? An ethical approach to patenting human genes and proteins
-
doi:10.1038/sj.tpj.6500140
-
Macer, D. R. J. (2002). Patent or perish? An ethical approach to patenting human genes and proteins. The Pharmacogenomics Journal, 2, 361-366. doi: 10. 1038/sj. tpj. 6500140.
-
(2002)
The Pharmacogenomics Journal
, vol.2
, pp. 361-366
-
-
Macer, D.R.J.1
-
11
-
-
27144444360
-
What are gene patents and why are people worried about them?
-
doi:10.1159/000087956
-
Merz, J. F., & Cho, M. K. (2005). What are gene patents and why are people worried about them? Community Genetics, 8(4), 203-208. doi: 10. 1159/000087956.
-
(2005)
Community Genetics
, vol.8
, Issue.4
, pp. 203-208
-
-
Merz, J.F.1
Cho, M.K.2
-
12
-
-
84869073490
-
Unblocked future: Why gene patents won't hinder whole genome sequencing and personalized medicine
-
Retrieved from
-
Price, W. N. (2012). Unblocked future: Why gene patents won't hinder whole genome sequencing and personalized medicine. Cardozo Law Review, 33(4), 1601-1631. Retrieved from http://www. cardozolawreview. com/.
-
(2012)
Cardozo Law Review
, vol.33
, Issue.4
, pp. 1601-1631
-
-
Price, W.N.1
-
13
-
-
84885853639
-
The ethics of genetic patenting and the subsequent implications on the future of health care
-
Retrieved from
-
Ratcliffe, S. (2011). The ethics of genetic patenting and the subsequent implications on the future of health care. Touro Law Review, 27(2), 435-460. Retrieved from http://digitalcommons. tourolaw. edu/lawreview/.
-
(2011)
Touro Law Review
, vol.27
, Issue.2
, pp. 435-460
-
-
Ratcliffe, S.1
-
14
-
-
80355135233
-
PARP inhibitors in breast cancer: BRCA and beyond
-
Retrieved from
-
Rios, J., & Puhalla, S. (2011). PARP inhibitors in breast cancer: BRCA and beyond. Oncology, 25(11), 1013. Retrieved from http://www. cancernetwork. com/.
-
(2011)
Oncology
, vol.25
, Issue.11
, pp. 1013
-
-
Rios, J.1
Puhalla, S.2
-
15
-
-
79957730140
-
Access to life-saving medicines and intellectual property rights: an ethical assessment
-
doi:10.1017/S0963180110000939
-
Schroeder, D., & Singer, P. (2011). Access to life-saving medicines and intellectual property rights: an ethical assessment. Cambridge Quarterly of Healthcare Ethics, 20(2), 279-289. doi: 10. 1017/S0963180110000939.
-
(2011)
Cambridge Quarterly of Healthcare Ethics
, vol.20
, Issue.2
, pp. 279-289
-
-
Schroeder, D.1
Singer, P.2
-
16
-
-
46349089710
-
Patenting and licensing in genetic testing: Ethical, legal and social issues
-
doi:10.1038/ejhg.2008.37
-
Soini, S., Ayme, S., & Matthijs, G. (2008). Patenting and licensing in genetic testing: Ethical, legal and social issues. European Journal of Human Genetics, 16, S10-S50. doi: 10. 1038/ejhg. 2008. 37.
-
(2008)
European Journal of Human Genetics
, vol.16
-
-
Soini, S.1
Ayme, S.2
Matthijs, G.3
-
17
-
-
0003578532
-
-
UNESCO, (Session 29/Resolution 16). Paris, France: UNESCO. Retrieved from
-
UNESCO. (1997). Universal Declaration on the Human Genome and Human Rights (Session 29/Resolution 16). Paris, France: UNESCO. Retrieved from http://www. unesco. org/.
-
(1997)
Universal Declaration on the Human Genome and Human Rights
-
-
|